SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-012117
Filing Date
2019-08-13
Accepted
2019-08-13 07:00:36
Documents
16
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35083
2 ex99-1.htm EX-99.1 135962
3 ex99-1_001.jpg GRAPHIC 4282
4 ex99-2.htm EX-99.2 14043
5 ex99-2_001.jpg GRAPHIC 69350
6 ex99-2_002.jpg GRAPHIC 204899
7 ex99-2_003.jpg GRAPHIC 31789
8 ex99-2_004.jpg GRAPHIC 104190
9 ex99-2_005.jpg GRAPHIC 95825
10 ex99-2_006.jpg GRAPHIC 31850
11 ex99-2_007.jpg GRAPHIC 82628
12 ex99-2_008.jpg GRAPHIC 94063
13 ex99-2_009.jpg GRAPHIC 151380
14 ex99-2_010.jpg GRAPHIC 91977
15 ex99-2_011.jpg GRAPHIC 26278
16 ex99-2_012.jpg GRAPHIC 62532
  Complete submission text file 0001493152-19-012117.txt   1634989
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 191018209
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1